TCM
ASTX

Touradji Capital Management’s ASTEX PHARMACEUTICALS, INC COM ASTX Stock Holding History

Touradji Capital Management’s Portfolio ASTX Stock Details ASTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2013
Q4 		– Sell
-25,000
Closed -$212K – 100
2013
Q3 		$212K Buy
+25,000
New +$158K 0.65% 46

Touradji Capital Management's ASTX Position: Q4 2013 in Review

Touradji Capital Management sold out of ASTEX PHARMACEUTICALS, INC COM (ASTX) in Q4 2013, closing a stake of 25,000 shares — an estimated $212K sold.

Touradji Capital Management first reported a position in ASTX in Q3 2013 and held it in 1 quarter. The position peaked at $212K in Q3 2013. 0 funds tracked by Wall St. Rank hold ASTX as of Q4 2013.

  • Touradji Capital Management reported no remaining ASTEX PHARMACEUTICALS, INC COM position as of Q4 2013 after selling out during the quarter.
  • Touradji Capital Management sold 25,000 ASTEX PHARMACEUTICALS, INC COM shares in Q4 2013, an estimated $212K.
  • Touradji Capital Management first reported a position in ASTEX PHARMACEUTICALS, INC COM in Q3 2013 and held it in 1 quarter.
  • Touradji Capital Management's ASTEX PHARMACEUTICALS, INC COM position peaked at $212K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ASTEX PHARMACEUTICALS, INC COM as of Q4 2013.

Based on Touradji Capital Management's 13F filing for Q4 2013, filed 11 Feb 2014.